QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 10/05/2018 --This report studies the global market size of Scopolamine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Scopolamine in these regions.
This research report categorizes the global Scopolamine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.

Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.

In 2017, the global Scopolamine market size was 16 million US$ and is forecast to 20 million US in 2025, growing at a CAGR of 3.0% from 2018. The objectives of this study are to define, segment, and project the size of the Scopolamine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Scopolamine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Scopolamine include

Alkaloids of Australia

Centroflora-cms

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Market Size Split by Type

Scopolamine Butylbromide

Scopolamine Hydrobromide

Scopolamine Base

Market Size Split by Application

Oral

Injection

Patches

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/741702/global-scopolamine-market

Market size split by Region
North America
Asia-Pacific
Europe
Central & South America
Middle East & Africa

Buy Full Scopolamine Market Report Now, Report delivery time within 24 hours https://www.qyresearch.com/settlement/pre/f0efd81a2513501b870fad898a0184ae,0,1,Global%20Scopolamine%20Market%20Insights%252C%20Forecast%20to%202025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com